North Carolina Attorney General Jeff Jackson discusses the $7.4 billion opioid settlement reached with Purdue Pharma, the ...

Indian pharmaceutical companies are preparing to flood the market with generic versions of Novo Nordisk’s semaglutide—sold ...

Kiniksa Pharmaceuticals sees strong growth from Arcalyst, aided by Medicare redesign. Learn about 2025 sales outlook & ...

Verona Pharma plc (NASDAQ:VRNA) is among the 10 Best Growth Stocks Under $100 to Buy Now. Analysts at Jefferies have raised the price target for Verona Pharma plc (NASDAQ:VRNA) to $110, up from $95, ...

Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has cleared the IND to initiate a Phase 1 clinical study of ORX142 in healthy volunteers. ORX142 is the second drug candidate ...

Appointment follows commencement of Phase 2 RESOLVE-1 trial of oral NLRP3 inflammasome inhibitor NT-0796 in patients with ...

Alfasigma, the prescription, OTC, and supplement-maker born in Bologna, Italy, announced in a press conference held in ...

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

Shares of UroGen Pharma gained momentum after the U.S. FDA approved Zusduri, a therapy for recurrent low-grade ...

During the first year of the collaboration, AbbVie will donate $233 for each strikeout made by a Cubs pitcher during home games throughout the regular season.

In our analysis, we have incorporated stocks under $100 that have high growth potential. Using the Finviz screener, the ...

However, nearly 10% of reports only disclosed activities in tax havens, according to the Fair Tax Foundation; in other news, ...